INSYS Therapeutics Inc (NASDAQ:INSY)

60.78
Delayed Data
As of Apr 17
 -0.21 / -0.34%
Today’s Change
20.52
Today|||52-Week Range
62.48
+44.17%
Year-to-Date

Today’s Trading

Previous close60.99
Today’s open60.38
Day’s range59.56 - 60.90
Volume269,735
Average volume (3 months)377,207
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-26.07%
Earnings growth (this year)+38.94%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+123.72%
P/E ratio58.7
Price/Sales6.53
Price/Book12.97

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.52-3.34%
RAREUltragenyx Pharmaceu...-2.05-3.15%
GWPHGW Pharmaceuticals P...+4.84+4.43%
MNKDMannkind Corp-0.14-2.70%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)$0.32
Annual revenue (last year)$222.1M
Annual profit (last year)$38.0M
Net profit margin17.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael L. Babich
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers